Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
EP Europace Journal

Abstract
Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions vary across different countries in Europe. The most recent recommendations for driving of ICD patients in Europe were published in 1997 and focused mainly on patients implanted for secondary prevention. In recent years there has been a vast increase in the number of patients with an ICD and in the percentage of patients implanted for primary prevention. The EHRA task force on ICD and driving was formed to reassess the risk of driving for ICD patients based on the literature available. The recommendations are summarized in the following table and are further explained in the document. Restriction for private driving Restriction for professional driving ICD implantation for secondary prevention Three months Permanent ICD implantation for primary prevention Four weeks Permanent After appropriate ICD therapy Three months Permanent After inappropriate ICD therapy Until measures to prevent inappropriate therapy are taken Permanent After replacement of the ICD One week Permanent After replacement of the lead system Four weeks Permanent Patients refusing ICD for primary prevention No restriction Permanent Patients refusing ICD implantation for secondary prevention Seven months Permanent
Contributors

Johan Vijgen
Author

Gianluca Botto
Author

John Camm
Author

Carl-Johan Hoijer
Author

Werner Jung
Author

Jean-Yves Le Heuzey
Author

Andrzej Lubinski
Author

Tone M. Norekvål
Author

Maurizio Santomauro
Author

Martin Schalij
Author

Jean-Paul Schmid
Author

Panos Vardas
Author
